CUAMC
OBIO icon

China Universal Asset Management Company’s Orchestra BioMed OBIO Stock Holding History

China Universal Asset Management Company’s Portfolio OBIO Stock Details OBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$41.1K Sell
9,530
-490
-5% -$2K ﹤0.01% 469
2026
Q1 		$42.6K Buy
10,020
+819
+9% +$3.49K ﹤0.01% 467
2025
Q4 		$38.2K Buy
+9,201
New +$37.1K ﹤0.01% 465

Other funds holding OBIO

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
RHJA
Rice Hall James & Associates San Diego, California $2.05B AUM 43.16% 1-Year Est. Return
DMKJ
David M. Knott Jr $189M AUM 67.72% 1-Year Est. Return
SAM
Simplify Asset Management Las Vegas, Nevada $7.19B AUM 6.88% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
DSC
Daytona Street Capital Saint Louis, Missouri $137M AUM
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return

China Universal Asset Management Company's OBIO Position: Q2 2026 in Review

China Universal Asset Management Company reduced its Orchestra BioMed (OBIO) stake by 4.9% in Q2 2026, selling an estimated $2K and leaving 9,530 shares worth $41.1K. The position accounts for ﹤0.01% of the portfolio, ranked #469.

China Universal Asset Management Company first reported a position in OBIO in Q4 2025 and has held it in 3 quarters since. The position peaked at $42.6K in Q1 2026. 36 funds tracked by Wall St. Rank hold OBIO as of Q2 2026.

  • China Universal Asset Management Company held 9,530 shares of Orchestra BioMed worth $41.1K as of Q2 2026.
  • China Universal Asset Management Company sold 490 Orchestra BioMed shares in Q2 2026, an estimated $2K.
  • Orchestra BioMed made up ﹤0.01% of China Universal Asset Management Company's portfolio in Q2 2026, its #469 holding.
  • China Universal Asset Management Company first reported a position in Orchestra BioMed in Q4 2025 and has held it in 3 quarters since.
  • China Universal Asset Management Company's Orchestra BioMed position peaked at $42.6K in Q1 2026.
  • 36 funds tracked by Wall St. Rank held Orchestra BioMed as of Q2 2026.

Based on China Universal Asset Management Company's 13F filing for Q2 2026, filed 24 Jul 2026.